
Neuroendocrine Tumours (NETs) – Vitamin D (Cholecalciferol / Ergocalciferol)
Vitamin D deficiency is demonstrably more common in people with neuroendocrine tumours (NETs) — but that does not automatically mean your deficiency is caused by
The Perfect Storm of Neuroendocrine Cancer by Ronny Allan, featured by Neuroendocrine Cancer UK
As featured by Neuroendocrine Cancer UK (formerly NET Patient Foundation)
It’s well known that Neuroendocrine Cancer can often be a very difficult to diagnose condition. However, what is less well known is the impact it has on those who are diagnosed. I’m one of the lucky ones, even though I still ended up with distant metastases. It does feel odd to say that having distant metastasis is lucky!
I consider my diagnosis to have been incidental as they were not investigating cancer – I suspect that’s the route for many cancer patients. I also think I was lucky because I had instant access to Neuroendocrine Cancer specialists and got quick treatment, and my follow up and support from a specialist centre were in place. I cope, but I wouldn’t say it’s easy living with metastatic and incurable cancer. As an advocate for a large online community, I do see many people struggle to get the same experience I had. I’m in no doubt that more must be done to help with earlier diagnosis, access to specialists and access to the right therapies at the right time. People must then be followed up with robust and expert-led surveillance and support regimes, and for the long term. This must become the normal experience; this must become the minimum standard of care.
This cancer is unlike others where the primary tumours are only located in a single organ. With Neuroendocrine disease, the primary tumour(s) can be found in many different organs and many different parts of the body. The aggressiveness of these tumours can range from indolent right up to very aggressive types. In aggressive types of cancer, stage is normally a key differentiator in prognostic terms, but with the less aggressive types of Neuroendocrine Cancers, often the grade can be more significant than the stage. There are a significant number of patients who have the lower grades but the highest stage and this is one of the huge challenges for physicians and patients to reconcile. An individual’s experiences will rely on their stage, grade, age, general physical condition and type of Neuroendocrine Neoplasm (a term encompassing well-differentiated Neuroendocrine Tumours and poorly differenced Neuroendocrine Carcinomas). Statistics indicate that early-stage diagnoses are on the increase, this is great news. But let’s be under no illusions, many people continue to be diagnosed late, often because of the relatively silent nature of the disease and often because of misdiagnosis and delay. More needs to be done to address both of these 2 issues.
Frequently, a correct diagnosis is just the beginning of a patient’s trauma. A late-stage diagnosis can still save a person’s life, but it can also present new challenges that will need specific attention to maintain quality of life. All these accumulative events and circumstances can create huge uncertainty, often with no signs of hope or a way out for the patient. Some of these events and circumstances will be sequential, but for many, they may appear simultaneously and within a relatively short period of time. For some, it can be like a “Perfect Storm” and even those who find themselves in the seemingly tranquil ‘eye’ of the storm, may still feel trapped and uncertain of what lies ahead. These ‘storm’ effects comprise:
Summary
Let’s be clear, Neuroendocrine Cancer actually wants to kill you. Without intervention, it will continue to plot its devious and destructive course, it will kill slowly but surely. Some are faster growing but they have the same traits, if left alone they just kill faster. Fortunately, due to earlier diagnosis, increasing awareness amongst the general public and healthcare professionals, and advances in medical science, the situation is improving slowly, but much more work needs to be done.
Going forward, Neuroendocrine Cancer patients need quality of life markers in addition to tumour and hormone markers.
Awareness plays a critical part in finding these tumours earlier in order that treatment and support can begin. Share this post and potentially save a life.
Footnote to the article title:
A perfect storm is a rare combination of events or circumstances creating an unusually bad situation. The term is most well known as the title to the 1997 Sebastian Junger non-fiction book, The Perfect Storm which is about a fishing-boat crew encountering a confluence of several coincidental weather events at sea.
Ronny Allan – Short Biography
Ronny Allan was diagnosed with metastatic Neuroendocrine Cancer in 2010. He resides in Hampshire UK with his wife close to his own family and dotes on his four grandsons. He enjoys family life, travel, reading, walking cycling and watching football. Ronny blogs about cancer and his survivorship experience via his website RonnyAllan.NET . The blog has been featured by several international organisations including Cancer Knowledge Network (CKN), Cure Magazine, Macmillan Cancer Support, WEGO Health, NET Research Foundation and Neuroendocrine Cancer UK. He is also a strong global advocate for Neuroendocrine Cancer awareness via his associated Facebook and Twitter sites.
He was the 2016 Winner in Best in Show Community, 2018 Winner Best in Show Blog, and Lifetime achievement in 2021, all in the WEGO Health Awards. In total so far, he’s had over 20 nominations for these awards proceeding to the finals on 6 occasions. He’s currently a member of the Strategic Advisory Board at Multimed Inc (publishers of Cancer Knowledge Network and Current Oncology), the Ipsen Patient Advisory Board and in 2019 and 2022 tenures, the WEGO Health Patient Leader Advisory Board. In June 2019, his blog broke through the 1 million views mark and then 2 million in October 2022.
Ronny is a regular speaker telling his patient story and other contributions to Neuroendocrine Cancer, including to audiences in Europe and North America. Ronny is passionate about modernising Neuroendocrine Cancer awareness and taking it to new audiences. He’s also a big believer in the patients included concept and his sites are accredited with Patient Included status.
Featured by Neuroendocrine Cancer UK (formerly NET Patient Foundation) here.
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional. Some content may be generated by AI which can sometimes be misinterpreted. Please check any references attached.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Thanks for reading.
Blog Facebook. Like this page please.
Personal Facebook. Like this page please.
Awareness Facebook Like this page please.
Follow me on X (formerly twitter)
Check out my online presentations
Check out my WEGO Health Awards


Vitamin D deficiency is demonstrably more common in people with neuroendocrine tumours (NETs) — but that does not automatically mean your deficiency is caused by

Words are very important to cancer patients, some people hang their hats on them and put their feet up, and some people google them until

Overview Many thanks for the support in January and February 2026. This is a double month newsletter due to my 27 day holiday! 2026 Blog

Vitamin B12 deficiency is demonstrably more common in people with neuroendocrine tumours (NETs) – what that means is there is a chance your deficiency as

When I was a young lad, I didn’t seem to have a fear of heights, not that I got many chances to test it but

When I was diagnosed with metastatic Neuroendocrine Cancer in 2010, there’s a lot of milestones I doubted I would reach. One is today and I

A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors. The primary purpose

Long-axial field-of-view (LAFOV) systems have changed the field of molecular imaging. Since their introduction, many PET centres have installed these next-generation digital systems to provide

Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumours and Other Somatostatin Receptor 2-Expressing Tumours Read the
I would also mention those who contributed to my “Tea Fund” which resides on PayPal. You don’t need a PayPal account as you can select a card but don’t forget to select the number of units first (i.e. 1 = £4, 2 = £8, 3 = £12, and so on), plus further on, tick a button to NOT create a PayPal account if you don’t need one. Clearly, if you have a PayPal account, the process is much simpler
Through your generosity, I am able to keep my sites running and provide various services for you. I have some ideas for 2023 but they are not detailed enough to make announcements yet.
This screenshot is from every single post on my website and depending on which machine you are using, it will either be top right of the post or at the bottom (my posts are often long, so scroll down!)
Subscribe to get the latest posts sent to your email.
Subscribe now to keep reading and get access to the full archive.